Vancouver, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The global RNA transcriptomics market size is expected to reach USD 20.75 Billion in 2032 and register a steady CAGR during the forecast period, according to latest analysis by Emergen Research. Some key factors driving market revenue growth include rising demand for customized and personalized medicines, increasing investments in biotechnology and pharmaceutical research, rising prevalence of gene mutations that are continuously occurring in cancer genes and genetic variations, and constant developments in medical infrastructure. RNA Transcriptomics provides a proper analysis of the entire RNA transcript which is present in an individual cell or cell population. This analysis thoroughly examines all the elements of the transcript to identify the transcriptional structure of genes and analyze the changing nature or behavior of each transcript under multiple development stages.
Various methods have been developed to perform transcriptome analysis such as microarrays, RNA interference, SAGE, polymerase chain reaction, and others. Polymerase chain reaction is a method that is used to make multiple copies of specific genes to identify and analyze a short sequence of RNA and DNA. These methods help scientists learn about diseases at a genomic level, which will help to develop clinical biomarkers, and identify and investigate multiple drug efficiency.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/610
Segments Covered in the report
| Report Details | Outcome |
| The market size in 2020 | USD 4.46 Billion |
| CAGR (2023–2032) | 13.6% |
| The revenue forecast in 2028 | USD 20.75 Billion |
| Base year for estimation | 2020 |
| Historical Data | 2018–2019 |
| Forecast period | 2023–2032 |
| Quantitative units | Revenue in USD Billion, and CAGR from 2023 to 2032 |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | Product, technology, application, end-use and regions. |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa. |
| Country scope | U.S.; Canada; Mexico; Germany; France; U.K.; BENELUX; Italy, Spain; Russia; Rest of Europe; China; Japan; South Korea; India; Rest of APAC; Brazil; Rest of LATAM; Saudi Arabia; UAE; South Africa; Turkey; Rest of MEA |
| Key companies profiled | Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., Illumina, Inc., GenXPro GmbH, Fluidigm Corporation, CD Genomics, Sequentia Biotech SL, and Acobiom. |
| Customization scope | 10 hours of free customization and expert consultation |
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/610
Competitive Landscape
The global RNA transcriptomics market is highly fragmented with a large number of key players focusing on research and development activities in order to increase revenue share and expand market footprint. Some major players in the market are:
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Agilent Technologies, Inc.
- Illumina, Inc.
- GenXPro GmbH
- Fluidigm Corporation
- CD Genomics
- Sequentia Biotech SL
- Acobiom
Strategic Developments
- In October 2019, Ambry Genetics introduced a transcriptomic test, +RNAinsight, which allows clinicians to simultaneously perform RNA and DNA testing and identify the risk of genetic mutations that may develop into cancer.
- In February 2019, Caris Life Sciences launched MI Transcriptome, which is a next-generation sequencing-based assay designed to detect and characterize molecular features of cancer cells to find more precise individualized treatment therapies for patients.
- In December 2018, 10x Genomics acquired Spatial Transcriptomics. This acquisition helped 10x Genomics to expand its expertise in gene expression analysis.
Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/610
Some Key Findings from the Report:
- Drug discovery segment accounted for a significantly higher revenue share in the global market in 2020. This can be attributed to increasing application of transcriptomics in drug discovery and for studying the efficacy of drugs.
- North America accounted for a revenue share of 32.2% in the global market in 2020. This can be attributed to rapid development of structure-based drug designs, growing focus on genomics and proteomics research, and rising expenditure on biopharmaceutical research.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/rna-transcriptomics-market
For the purpose of this report, Emergen Research has segmented the global RNA transcriptomics market based on product, technology, application, end-use, and region:
- Product Outlook (Revenue: USD Billion; 2023–2032)
- Reagents
- Instruments
- Software
- Service
- Technology Outlook (Revenue: USD Billion; 2023–2032)
- Microarrays
- Polymerase Chain Reaction
- RNA Sequencing
- RNA Interference
- Application Outlook (Revenue: USD Billion; 2023–2032)
- Clinical Diagnostics
- Toxicogenomics
- Drug Discovery
- Comparative Transcriptomics
- End-use Outlook (Revenue: USD Billion; 2023–2032)
- Hospitals
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Regional Outlook (Revenue: USD Billion; 2023–2032)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- BENELUX
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Turkey
- Rest of MEA
- North America
Curated Reports You Shouldn't Miss: Dive In Now!
CRISPR Technology Market By Product (Enzymes, Kits and Reagents, Guide RNA, Others), By Application (Biomedical, Agriculture, Industrial, Others), By End User (Pharmaceutical and Biotechnology Companies, Academics and Government Research Institutes, CROs) and By Regions Forecasts to 2027
Synthetic Blood Substitutes Market, By Source (Blood and Stem Cell), By Type (Hemoglobin-based Oxygen Carriers and Perfluorocarbons), By Application (Anemia and Injury), By End-User (Hospitals & Clinics and Military), and By Region Forecast to 2030
Neuromorphic Computing Market, By Offering (Hardware, Software), By Deployment (Edge Computing, Cloud Computing), By Application (Image Recognition, Signal Recognition, Data Mining), By Industry (Automotive, Healthcare) By Region Forecast To 2030
Cell-Free DNA (cfDNA) Testing Market By Type (Cell-free fetal DNA (NIPT), Circulating tumor DNA, Donor-derived cell-free DNA), By Technology (MPSS, t-MPS, SNP, Others), Application (Transplantation, Gynecology, Oncology), By Region Forecasts to 2027
Peritoneal Dialysis Market By Product (Peritoneal Dialysis Solution, Peritoneal Dialysis Set, Device, Catheter), By Type (CAPD, APD), By End-User (Home-Based Dialysis, Dialysis Center & Hospital Based Dialysis) and Regions Forecasts to 2027
Breath Analyzer Market, By Technology (Fuel Cells, Semiconductor Oxide Sensors, and Other Technologies), By Application (Alcohol Detection, Drug Abuse Detection, and Medical Applications), By End-Use, and By Region Forecast to 2032
Assisted Reproductive Technology (ART) Market Size, Share, Trends, By Procedure, By Technology, By End-use, and By Region Forecast to 2028
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com/
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Explore Our Japanese Version: RNA Transcriptomics Market
Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights
Read our Press Release @ https://www.emergenresearch.com/press-release/global-rna-transcriptomics-market
